Diazepam

Generic Name
Diazepam
Brand Names
Diastat, Valium, Valtoco 5 Mg Dose Kit
Drug Type
Small Molecule
Chemical Formula
C16H13ClN2O
CAS Number
439-14-5
Unique Ingredient Identifier
Q3JTX2Q7TU
Background

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an an...

Indication

In general, diazepam is useful in the symptomatic management of mild to moderate degrees of anxiety in conditions dominated by tension, excitation, agitation, fear, or aggressiveness such as may occur in psychoneurosis, anxiety reactions due to stress conditions, and anxiety states with somatic expression.
...

Associated Conditions
Acute Agitation, Alcohol Withdrawal Delirium, Alcohol Withdrawal Hallucinosis, Anxiety, Anxiety Disorders, Apprehension, Refractory Epilepsy, Skeletal Muscle Spasms, Status Epilepticus, Stress (Psychology), Tension, Tremor, Convulsive disorders, Intermittent distinct from a patient’s usual seizure pattern, stereotypic episode Epileptic seizure
Associated Therapies
Sedation, Perioperative management therapy

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

First Posted Date
2011-03-18
Last Posted Date
2013-07-09
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
24
Registration Number
NCT01318369
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Prevention of Posttraumatic Stress Disorder (PTSD) With Diazepam

Phase 4
Conditions
Interventions
First Posted Date
2010-10-15
Last Posted Date
2013-03-20
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
40
Registration Number
NCT01221883
Locations
🇮🇱

Hadassah Medical Organitation, Jerusalem, Israel

Exploring the Effects of Diazepam and Lorazepam

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2008-06-12
Last Posted Date
2009-09-17
Lead Sponsor
University Hospital, Strasbourg, France
Target Recruit Count
22
Registration Number
NCT00696033
Locations
🇫🇷

Centre d'investigation clinique, hôpital civil, Strasbourg, France

🇫🇷

Clinique psychiatrique, hôpital civil, Strasbourg, France

A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2007-08-31
Last Posted Date
2007-08-31
Lead Sponsor
Stanford University
Target Recruit Count
55
Registration Number
NCT00523185
Locations
🇺🇸

Palo Alto Veterans Affairs Hospital System, Palo Alto, California, United States

🇺🇸

Stanford Hospital and Clinics, Stanford, California, United States

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-05-17
Last Posted Date
2011-10-26
Lead Sponsor
University of Utah
Target Recruit Count
358
Registration Number
NCT00326612
Locations
🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

Biofeedback for Dyssynergic Constipation

Not Applicable
Completed
Conditions
First Posted Date
2005-08-05
Last Posted Date
2010-01-13
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
117
Registration Number
NCT00127257
Locations
🇺🇸

University of North Carolina Department of Medicine, Chapel Hill, North Carolina, United States

Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus

Phase 3
Completed
Conditions
First Posted Date
1999-10-19
Last Posted Date
2005-06-24
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
210
Registration Number
NCT00004297
© Copyright 2024. All Rights Reserved by MedPath